KATHRYN TITE: Open Payments
NPI 1093423832 · DANVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 17 payments from 10 companies in 2025. Trend: 2023 $274 · 2024 $520 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $146 |
| Novo Nordisk Inc | 3 | $56 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Viatris Specialty LLC | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: AIRSUPRA, Ozempic, ZORYVE, INJECTAFER, QULIPTA, LEQVIO, YUPELRI, CAPLYTA.
Industry payments across IL — which companies pay providers there.
